Industry Insights
Cost-saving strategies for Pharmacy Benefits Managers.
Industry Insight
Industry Insight
May 27, 2025
Biosimilar Savings
Scripius is poised to make a decisive move by removing Stelara from our standard Large Employer formularies as of July 1, 2025.
Industry Insight
Industry Insight
Nov 04, 2024
Controlling Costs in 2025
Scripius' 2024 drug coverage changes aim to reduce costs for diabetes and arthritis meds in 2025.
Industry Insight
Industry Insight
Jul 31, 2024
Adopting Biosimilars
Strategies and insights on adopting biosimilars, featuring expert Matt Mitchell.
Industry Insight
Industry Insight
Apr 04, 2024
Creating RX Savings
Scripius' 2023 drug coverage changes aim to cut costs and improve access in 2024.
Industry Insight
Industry Insight
Oct 03, 2023
GLP-1 Utilization
If it doesn’t have one already, your health plan needs a GLP-1 strategy.
Industry Insight
Industry Insight
Aug 10, 2023
Quarters 1 & 2 (2023) Market Update
Scripius' quick Rx market actions save money and improve drug access.
